NEWARK — A global upstart in fertility research and science has acquired Reproductive Associates of DE (RADfertility), a fertility center that has offices in Newark, Wilmington and Dover as part of its plans to target patients in the Mid Atlantic region.
CCRM Fertility, a clinic that offers the most advanced fertility research and treatments in the country, acquired the Delaware health care firm earlier this month. Terms of the acquisition were not disclosed. Branding on the Delaware facilities will stay RADfertility, although CCRM officials are still working through the details of what a changeover could look like.
“We’re just starting to partner closely with the team. We’re looking at what equipment can be upgraded, where patients are in the process and what’s working and how we can build off of that,” CCRM Fertility Chief Operating Officer Eleanor Harte told the Delaware Business Times. “From there, we’ll look at where support from a network could be most helpful.”
Founded in 1987, CCRM Fertility has among the top clinical quality expertise in in vitro fertilization (IVF) procedures, with some of the highest success rates across the industry. The company also offers advanced fertility treatments, IVF assessments, diagnostic fertility preservation, genetic testing, egg donation and more.
In addition, CCRM leverages its own data through the expertise of its in-house team of reproductive endocrinologists, embryologists and geneticists.
“Our lab really started out of the core technology from our founder Dr. Bill Schoolcraft in IVF, and we’re starting to explore how to automate our properties across the lab to ensure we’re delivering the highest quality of care possible,” Harte said.
Over the last 35 years, CCRM has expanded to major cities across the United States like New York, Los Angeles, Washington D.C., Houston and more. With 36 locations, the company targets 12 major metropolitan areas, including Toronto, Canada. The acquisition of the RADfertility sites now adds Delaware to that footprint – adding more options for clients in the Mid-Atlantic region.
“Our goal is to grow but with a focus on quality and to make sure we certainly provide the best care to existing patients,” she said. “We’re also seeing an increased benefit to having our sites work together. So say someone raises their eggs in New York but wants to do IVF treatment in Delaware, we can make that possible through our network.”
RADfertility was established in 1995 and has six board-certified reproductive endocrinologists, as well as state-of-the art fertility care through clinical and lab teams. In all, RADfertility centers will add 14 employees to the CCRM network, which has about 1,000 employees.
“We are thrilled to become part of the CCRM Fertility network and to continue offering outstanding fertility care services to our community,” RADFertility Founder Barbara McGuirk said in a statement.
“The IVF laboratory technology and advances developed by CCRM are truly the best in the world, and will now be directly available to our patients”, added Ronald Feinberg. Feinberg founded and directed RADfertility’s IVF program in 1997.
Both McGuirk and Feinberg will continue on with the health care service, with McGuirk serving as director of reproductive surgery and Feinberg as Chief Medical Officer at RADfertility.
Looking to the future transition, Harte said that CCRM officials will continue to examine patient needs, demographics, and commuter times.
“We do have one main hub where we have surgery centers and the lab and clinics. We’re starting to build out satellite clinics to monitor database support,” she said. “To reduce the number of treatments, if someone’s coming to a community a further distance, we’ll definitely be evaluating our footprint.”